ERBB2 and breast carcinoma: Thus far genomic sequencing of isolated CSF-CTCs has been achieved in patients with LM from breast cancer expressing human epidermal growth factor receptor 2 (HER2) and demonstrated similarities between CSF-CTCs and tumor cells from primary site in addition to several genetic alterations private to CSF-CTC (38, 42–44).